SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Altor BioScience Corporation and the Melanoma Research Alliance to Co-Support Clinical Studies of Altor’s Novel IL-15 Superagonist for Metastatic Melanoma